Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 367
interventional 299
Observational 61
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 106
Drug|placebo 71
Device 48
Procedure 37
Device|Procedure 8
Other 5
Device|Drug 4
Behavioral 3
Biological 2
Device|Drug|Procedure 2
Device|Other 2
Dietary Supplement|placebo 2
Drug|Procedure 2
Biological|Device|Procedure 1
Biological|Drug 1
Biological|placebo 1
Dietary Supplement 1
Dietary Supplement|Drug 1
Dietary Supplement|Other|Procedure 1
Drug|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 63
Korea, Republic of 34
NA 28
Egypt 12
Taiwan 11
France 10
Japan 10
Canada 9
Italy 9
China 8
Germany 6
Netherlands 5
Australia 4
Hong Kong 4
India 4
Spain 4
United States|Canada 4
Brazil 3
Finland 3
Turkey 3
United Kingdom 3
Australia|New Zealand 2
Israel 2
Japan|Korea, Republic of 2
Russian Federation 2
Australia|Austria|Belgium|France|Germany|Greece|Italy|Mexico|Netherlands|Poland 1
Australia|Austria|Canada|Czech Republic|France|Germany|Italy|Korea, Republic of|Slovakia|Taiwan|United Kingdom 1
Australia|Belgium|Canada|Chile|Colombia|Denmark|Finland|Greece|Italy|Latvia|Lithuania|Poland|Slovakia|Spain|United Kingdom 1
Australia|France|Germany|Greece|Hungary|Netherlands|Spain 1
Australia|Georgia|Taiwan 1
Austria|Belarus|Belgium|Czechia|France|Germany|Italy|Netherlands|Poland|Slovakia|United Kingdom 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hungary|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Spain|Sweden|United Kingdom 1
Austria|Switzerland 1
Bangladesh 1
Belarus|Bulgaria|Czech Republic|France|Germany|Italy|Macedonia, The Former Yugoslav Republic of|Netherlands|Romania|United Kingdom 1
Belgium 1
Belgium|Italy|Spain|Switzerland|United Kingdom 1
Bulgaria|New Zealand 1
China|Japan|Korea, Republic of|Taiwan 1
Colombia|Ecuador|Guatemala|Mexico 1
Czech Republic|Netherlands|Slovakia 1
Czechia|Dominican Republic|Sweden 1
Denmark|Germany|United Kingdom 1
Dominican Republic 1
Dominican Republic|Panama 1
France|Germany|Greece|Italy|Netherlands|Romania|Spain|United Kingdom 1
France|Germany|Italy|Russian Federation|Spain 1
France|Italy|Portugal|Spain 1
Germany|Austria|Belarus|Belgium|Czech Republic|France|Hungary|Italy|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom 1
Hungary 1
Iran, Islamic Republic of 1
Japan|Taiwan 1
Lebanon 1
Mexico 1
New Zealand|Singapore 1
Norway 1
Portugal 1
Russian Federation|Ukraine 1
Singapore 1
Spain|Czech Republic|France|Germany|Italy 1
Spain|United States|Canada|Czechia|France|Germany|Italy|Poland|United Kingdom 1
Switzerland 1
Thailand 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|Iceland|Israel|Italy|Puerto Rico|Korea, Republic of|Lithuania|Mexico|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|Taiwan|Thailand|Tunisia|Turkey|United Kingdom| 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Greece|Italy|Mexico|Poland|Russian Federation|Turkey 1
United States|Argentina|Germany|Italy|Mexico 1
United States|Australia|Bulgaria|Canada|Denmark|Finland|Greece|Hungary|Israel|Netherlands|Norway|Poland|Portugal|Romania|South Africa|Spain|Sweden 1
United States|Australia|Canada 1
United States|Australia|Canada|New Zealand|Russian Federation|Ukraine 1
United States|Australia|New Zealand|United Kingdom 1
United States|Austria|Italy 1
United States|Belgium|Canada|Czech Republic|Italy|Poland 1
United States|Canada|Czechia|France|Germany|Korea, Republic of|Philippines|Poland 1
United States|Canada|France|Germany|Greece|Italy|Mexico|Portugal|Russian Federation 1
United States|France|Italy|United Kingdom 1
United States|Greece|Portugal 1
United States|India 1
United States|Puerto Rico 1
United States|Spain|Belgium|Canada|Hungary|Lithuania|Poland 1

Sites per Study

Site_count Study_Count
1 193
2 9
3 7
4 5
5 3
6 7
7 3
8 5
9 4
10 1
11 4
12 1
13 3
14 3
15 5
16 3
17 4
19 2
26 1
27 2
28 1
30 1
31 1
32 1
34 1
35 1
41 2
42 1
43 1
44 1
45 1
46 2
47 1
48 1
52 1
54 1
55 1
58 2
65 1
67 1
69 1
70 1
76 1
79 2
80 1
95 1
98 1
118 1
119 1
504 1

Phase

Phase Study_Count
N/A 102
Phase 4 57
Phase 3 51
Phase 2 38
Phase 1 34
Phase 1/Phase 2 8
Phase 2/Phase 3 7
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 81
2 146
3 33
4 12
5 3
6 1
8 1
14 1
NA 21

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1.00 9.0000 12.00000 15.0 20.0 13.0 42.0000 20.0000
1st Qu. 10.75 30.0000 28.50000 31.5 85.0 46.5 246.5000 63.0000
Median 20.50 80.0000 35.00000 50.0 145.5 76.0 462.0000 130.0000
Mean 20.50 640.1471 38.79412 77.0 220.5 278.0 637.9608 303.4561
3rd Qu. 30.25 157.5000 44.50000 105.5 314.5 353.0 636.5000 424.0000
Max. 40.00 53480.0000 86.00000 200.0 919.0 1058.0 4844.0000 1993.0000

Trial Group Type

group_type Group_Count
Experimental 300
Active Comparator 153
Placebo Comparator 75
NA 21
Other 19
No Intervention 11
Sham Comparator 5

Intervention Model

intervention_model Study_Count
Parallel Assignment 175
Single Group Assignment 84
Crossover Assignment 38
Factorial Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 259
Prevention 9
Basic Science 8
Other 6
Diagnostic 5
Supportive Care 5
NA 4
Device Feasibility 1
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
NA 25
United States 9
Korea, Republic of 6
France 4
Switzerland 2
Canada 1
China 1
Colombia 1
Denmark 1
Germany 1
Greece|Italy|Portugal|Spain|Turkey 1
Israel 1
Italy 1
Norway 1
Philippines 1
Poland 1
Singapore 1
Sweden 1
Turkey 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 54
2 2
5 2
18 1
27 1
73 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 74.000
Median 300.000
Mean 4045.883
3rd Qu 3716.000
Max 54459.000

Observation Model

observational_model Study_Count
Cohort 43
Case-Only 6
NA 5
Case Control 3
Other 3
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 40
Retrospective 17
Cross-Sectional 2
Cross-Sectional, Prospective 1
Other 1

Registries

Studies by Country

Country Study_Count
Philippines 2
China 1
Egypt 1
Italy 1
Korea, Republic of 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 6
4 1

Enrollment Metrics

Measure Registries
Min 200.0000
1st Qu 287.5000
Median 400.0000
Mean 428.5714
3rd Qu 450.0000
Max 925.0000

Registry Model

observational_model Study_Count
Case-Only 2
Cohort 2
Ecologic or Community 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 5
Cross-Sectional 2

Follow-up

target_duration Study_Count
1 Year 2
12 Months 2
2 Years 1
3 Months 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03318991 Clinical Outcomes of Laser Prostatectomy https://ClinicalTrials.gov/show/NCT03318991 Enrolling by invitation National Taiwan University 2018-10-19
NCT03305861 Green LEP vs ThuLEP in Management of Marked Enlarged Prostate https://ClinicalTrials.gov/show/NCT03305861 Recruiting Mansoura University 2019-12-01
NCT03297281 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) https://ClinicalTrials.gov/show/NCT03297281 Recruiting Clinique Pasteur 2021-11-30
NCT03264482 High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH https://ClinicalTrials.gov/show/NCT03264482 Active, not recruiting Mansoura University 2018-12-02
NCT03246880 Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients https://ClinicalTrials.gov/show/NCT03246880 Completed Chong Kun Dang Pharmaceutical 2016-04-30
NCT03240939 Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil https://ClinicalTrials.gov/show/NCT03240939 Completed Yuyu Pharma, Inc. 2017-07-07
NCT03239652 Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03239652 Recruiting National Cheng-Kung University Hospital 2020-06-30
NCT03230721 ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH https://ClinicalTrials.gov/show/NCT03230721 Completed I.M. Sechenov First Moscow State Medical University 2017-04-22
NCT03194737 Prostatic Urethral Lift in Subject With Acute Urinary Retention https://ClinicalTrials.gov/show/NCT03194737 Active, not recruiting NeoTract, Inc. 2018-12-31
NCT03191734 French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue https://ClinicalTrials.gov/show/NCT03191734 Completed PROCEPT BioRobotics 2018-07-02
NCT03167294 AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03167294 Completed PROCEPT BioRobotics 2016-06-30
NCT03157726 Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate https://ClinicalTrials.gov/show/NCT03157726 Recruiting Zhujiang Hospital 2020-06-06
NCT03144596 The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil https://ClinicalTrials.gov/show/NCT03144596 Completed Kocatepe University 2016-02-03
NCT03125889 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II https://ClinicalTrials.gov/show/NCT03125889 Completed PROCEPT BioRobotics 2017-04-18
NCT03125863 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03125863 Completed PROCEPT BioRobotics 2016-09-03
NCT03123250 Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II https://ClinicalTrials.gov/show/NCT03123250 Active, not recruiting PROCEPT BioRobotics 2018-03-27
NCT03109925 Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement https://ClinicalTrials.gov/show/NCT03109925 Recruiting University Hospital Southampton NHS Foundation Trust 2019-10-31
NCT03055624 Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03055624 Completed University of California, San Diego 2019-02-18
NCT03052049 Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres https://ClinicalTrials.gov/show/NCT03052049 Active, not recruiting Northwestern University 2020-03-01
NCT02977832 Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02977832 Completed IRCCS Policlinico S. Matteo 2016-07-31
NCT02972268 Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH https://ClinicalTrials.gov/show/NCT02972268 Completed Jeil Pharmaceutical Co., Ltd. 2017-11-02
NCT02962674 To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH. https://ClinicalTrials.gov/show/NCT02962674 Active, not recruiting ProstaCare Singapore Pte. Ltd. 2019-09-30
NCT02961114 Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy https://ClinicalTrials.gov/show/NCT02961114 Active, not recruiting Healeon Medical Inc 2022-12-31
NCT02943070 Rezum I Pilot Study for BPH https://ClinicalTrials.gov/show/NCT02943070 Completed Boston Scientific Corporation 2013-02-28
NCT02940392 Rezum FIM Optimization https://ClinicalTrials.gov/show/NCT02940392 Completed Boston Scientific Corporation 2012-12-31
NCT02930889 Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02930889 Recruiting University of Minnesota 2020-10-31
NCT02869971 Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02869971 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT02855892 A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH https://ClinicalTrials.gov/show/NCT02855892 Completed GemVax & Kael 2016-10-31
NCT02846467 Information Improvement for Surgical Patients Through Portable Video Media https://ClinicalTrials.gov/show/NCT02846467 Completed Hospital Universitario Puerto Real 2015-10-31
NCT02839122 A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02839122 Completed Yuyu Pharma, Inc. 2016-09-30
NCT02822924 Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02822924 Recruiting Chinese University of Hong Kong 2020-04-30
NCT02786290 The Zenflow Spring System Feasibility and Safety Study https://ClinicalTrials.gov/show/NCT02786290 Active, not recruiting Zenflow, Inc. 2019-12-31
NCT02778243 Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level https://ClinicalTrials.gov/show/NCT02778243 Completed Hopital Foch 2016-11-12
NCT02757963 Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years https://ClinicalTrials.gov/show/NCT02757963 Completed GlaxoSmithKline 2017-02-27
NCT02757768 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02757768 Completed Astellas Pharma Inc 2018-08-14
NCT02715401 PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02715401 Completed Hanmi Pharmaceutical Company Limited 2015-11-30
NCT02715024 Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms https://ClinicalTrials.gov/show/NCT02715024 Completed Astellas Pharma Inc 2011-04-30
NCT02712411 Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02712411 Completed Hanmi Pharmaceutical Company Limited 2015-08-31
NCT02681471 Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT02681471 Completed Istanbul University 2015-04-30
NCT02676544 Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) https://ClinicalTrials.gov/show/NCT02676544 Recruiting Rhode Island Hospital 2020-12-31
NCT02656173 A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) https://ClinicalTrials.gov/show/NCT02656173 Completed Astellas Pharma Inc 2017-07-21
NCT02645890 Study to Compare the Safety and Pharmacokinetics of CKD-397 https://ClinicalTrials.gov/show/NCT02645890 Completed Chong Kun Dang Pharmaceutical 2015-12-31
NCT02637960 Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02637960 Completed Vantia Ltd 2017-07-31
NCT02634489 EC905 Pharmacokinetic Profile Study https://ClinicalTrials.gov/show/NCT02634489 Completed Astellas Pharma Inc 2009-07-31
NCT02625545 Study of Median Lobe Prostatic UroLift Procedure https://ClinicalTrials.gov/show/NCT02625545 Completed NeoTract, Inc. 2017-05-30
NCT02615782 A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02615782 Completed Chong Kun Dang Pharmaceutical 2016-04-30
NCT02592473 Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02592473 Recruiting University of Virginia 2021-11-30
NCT02524236 Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. https://ClinicalTrials.gov/show/NCT02524236 Completed Beni-Suef University 2016-11-30
NCT02509104 Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02509104 Completed GlaxoSmithKline 2015-10-10
NCT02506465 Pivotal Study to Assess the Safety and Effectiveness of the iTind Device https://ClinicalTrials.gov/show/NCT02506465 Completed Medi-Tate Ltd. 2018-10-31
NCT02505919 Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) https://ClinicalTrials.gov/show/NCT02505919 Completed PROCEPT BioRobotics 2017-07-14
NCT02494349 The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. https://ClinicalTrials.gov/show/NCT02494349 Completed Jeil Pharmaceutical Co., Ltd. 2015-11-30
NCT02447367 Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT02447367 Completed Jeil Pharmaceutical Co., Ltd. 2015-09-30
NCT02429219 Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate https://ClinicalTrials.gov/show/NCT02429219 Completed University of Magdeburg 2015-02-28
NCT02423759 A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy https://ClinicalTrials.gov/show/NCT02423759 Completed Mansoura University 2017-01-16
NCT02417844 Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. https://ClinicalTrials.gov/show/NCT02417844 Completed Boehringer Ingelheim 2015-05-31
NCT02417831 Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. https://ClinicalTrials.gov/show/NCT02417831 Completed Boehringer Ingelheim 2015-05-31
NCT02390882 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH https://ClinicalTrials.gov/show/NCT02390882 Completed Hanmi Pharmaceutical Company Limited 2015-05-31
NCT02366975 TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST https://ClinicalTrials.gov/show/NCT02366975 Completed University of Florence 2017-01-31
NCT02346500 Ultrasound-Guided Photoselective Vaporization of the Prostate https://ClinicalTrials.gov/show/NCT02346500 Completed Johns Hopkins University 2016-11-26
NCT02332538 HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH https://ClinicalTrials.gov/show/NCT02332538 Completed Mansoura University 2016-07-31
NCT02326454 A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02326454 Completed Light Sciences Oncology 2017-03-29
NCT02313233 Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02313233 Completed Golden Biotechnology Corporation 2015-05-31
NCT02303769 Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS https://ClinicalTrials.gov/show/NCT02303769 Completed GL Pharm Tech Corporation 2015-05-31
NCT02283684 GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT https://ClinicalTrials.gov/show/NCT02283684 Completed Mansoura University 2015-11-30
NCT02252367 Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02252367 Active, not recruiting University of Florence 2019-01-31
NCT02245490 Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms https://ClinicalTrials.gov/show/NCT02245490 Completed Boehringer Ingelheim 2004-04-30
NCT02244294 FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02244294 Completed Boehringer Ingelheim 2005-06-30
NCT02244255 FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244255 Completed Boehringer Ingelheim 2000-06-30
NCT02244242 Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244242 Completed Boehringer Ingelheim 1999-08-31
NCT02244229 Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients https://ClinicalTrials.gov/show/NCT02244229 Completed Boehringer Ingelheim 2000-11-30
NCT02239484 Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin https://ClinicalTrials.gov/show/NCT02239484 Completed Hanmi Pharmaceutical Company Limited 2014-09-30
NCT02195622 Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures https://ClinicalTrials.gov/show/NCT02195622 Completed Indiana Kidney Stone Institute 2015-01-31
NCT02184585 Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States https://ClinicalTrials.gov/show/NCT02184585 Completed GlaxoSmithKline 2015-02-23
NCT02180997 Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin https://ClinicalTrials.gov/show/NCT02180997 Completed Jeil Pharmaceutical Co., Ltd. 2015-03-31
NCT02180789 A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation https://ClinicalTrials.gov/show/NCT02180789 Completed Astellas Pharma Inc 2015-01-31
NCT03385161 Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03385161 Completed Cairo University 2015-06-30
NCT02167919 Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02167919 Completed University of North Carolina, Chapel Hill 2017-05-01
NCT02167009 Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams https://ClinicalTrials.gov/show/NCT02167009 Recruiting Tampa General Hospital 2020-05-31
NCT02145208 Study to Assess the Efficacy of Medi-Tate iTind Device https://ClinicalTrials.gov/show/NCT02145208 Active, not recruiting Medi-Tate Ltd. 2017-12-31
NCT02026908 Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02026908 Active, not recruiting Northwestern University 2020-06-01
NCT02121613 PERmixon® in LUTS Evaluation Study (PERLES) https://ClinicalTrials.gov/show/NCT02121613 Completed Pierre Fabre Medicament 2016-06-30
NCT02106182 Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02106182 Completed JW Pharmaceutical 2016-03-02
NCT02074644 Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02074644 Completed Hospital St. Louis, Lisbon, Portugal 2019-03-03
NCT02072499 KTP Green Light Prostatectomy Compared With Open Prostatectomy https://ClinicalTrials.gov/show/NCT02072499 Completed University of Helsinki 2017-06-30
NCT02058368 Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02058368 Completed GlaxoSmithKline 2017-03-03
NCT01301599 Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01301599 Completed Samsung Medical Center 2013-07-31
NCT01294592 Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement https://ClinicalTrials.gov/show/NCT01294592 Completed GlaxoSmithKline 2013-10-17
NCT01294150 The Safety and Effectiveness of UroLift: LIFT Pivotal Study https://ClinicalTrials.gov/show/NCT01294150 Completed NeoTract, Inc. 2013-02-28
NCT01275521 A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy https://ClinicalTrials.gov/show/NCT01275521 Completed University Hospital, Bordeaux 2015-04-28
NCT02054013 Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02054013 Active, not recruiting Cantonal Hospital of St. Gallen 2017-09-19
NCT02051036 Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study https://ClinicalTrials.gov/show/NCT02051036 Completed Korean Medicine Hospital of Pusan National University 2015-12-31
NCT02041767 Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration https://ClinicalTrials.gov/show/NCT02041767 Completed Assistance Publique - Hôpitaux de Paris 2015-01-31
NCT02038868 A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT02038868 Completed Astellas Pharma Inc 2014-04-04
NCT02015806 Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices https://ClinicalTrials.gov/show/NCT02015806 Completed Brigham and Women’s Hospital 2015-02-28
NCT02011308 KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate) https://ClinicalTrials.gov/show/NCT02011308 Completed University of Helsinki 2015-10-31
NCT01966614 Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH https://ClinicalTrials.gov/show/NCT01966614 Completed Sophiris Bio Corp 2015-12-31
NCT01963312 Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. https://ClinicalTrials.gov/show/NCT01963312 Completed Fundacion Miguel Servet 2018-04-30
NCT01957189 This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples https://ClinicalTrials.gov/show/NCT01957189 Completed GlaxoSmithKline 2014-01-22
NCT01952912 Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates https://ClinicalTrials.gov/show/NCT01952912 Completed Fuzhou General Hospital 2007-06-30
NCT01942551 Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride https://ClinicalTrials.gov/show/NCT01942551 Completed Dongkook Pharmaceutical Co., Ltd. 2013-12-31
NCT01939184 Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01939184 Completed Warner Chilcott 2014-03-31
NCT01937871 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) https://ClinicalTrials.gov/show/NCT01937871 Completed Eli Lilly and Company 2015-12-31
NCT01924988 Prostate Embolization for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01924988 Completed Georgetown University 2017-04-30
NCT01922375 Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01922375 Completed Dong-A ST Co., Ltd. 2012-09-30
NCT01912339 Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT01912339 Completed Boston Scientific Corporation 2015-03-31
NCT01892332 The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients https://ClinicalTrials.gov/show/NCT01892332 Completed Yonsei University 2014-01-31
NCT01876706 UroLift System TOlerability and ReCovery When Administering Local Anesthesia https://ClinicalTrials.gov/show/NCT01876706 Completed NeoTract, Inc. 2014-10-31
NCT01846793 Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) https://ClinicalTrials.gov/show/NCT01846793 Completed Nymox Corporation 2014-10-31
NCT01835860 Prostatic Artery Embolization for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01835860 Completed Saskatchewan Health Authority - Regina Area 2015-12-31
NCT03350529 MRI Guided Transurethral HIFU for Various Prostate Diseases https://ClinicalTrials.gov/show/NCT03350529 Active, not recruiting Turku University Hospital 2020-12-31
NCT01781117 Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01781117 Completed Samsung Medical Center 2016-11-30
NCT01777269 Prospective Sexual Function Study for BPH Subjects https://ClinicalTrials.gov/show/NCT01777269 Completed GlaxoSmithKline 2016-04-05
NCT01757769 Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01757769 Completed Recordati Industria Chimica e Farmaceutica S.p.A. 2013-03-31
NCT01747577 Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) https://ClinicalTrials.gov/show/NCT01747577 Completed Astellas Pharma Inc 2013-10-31
NCT01732991 Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound https://ClinicalTrials.gov/show/NCT01732991 Completed University Hospital, Tours 2015-03-31
NCT01716104 Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression https://ClinicalTrials.gov/show/NCT01716104 Completed Materia Medica Holding 2016-11-30
NCT01678313 Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels https://ClinicalTrials.gov/show/NCT01678313 Completed Buddhist Tzu Chi General Hospital 2013-08-31
NCT01675895 Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration https://ClinicalTrials.gov/show/NCT01675895 Completed Diskapi Teaching and Research Hospital 2011-07-31
NCT01665586 Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study https://ClinicalTrials.gov/show/NCT01665586 Completed Yonsei University 2013-09-30
NCT01657851 Bioequivalence - Duodart Against Avodart & Omnic https://ClinicalTrials.gov/show/NCT01657851 Completed GlaxoSmithKline 2012-12-05
NCT01637701 Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate https://ClinicalTrials.gov/show/NCT01637701 Completed Fuzhou General Hospital 2006-12-31
NCT01631149 Effect of Deep BLock on Intraoperative Surgical Conditions https://ClinicalTrials.gov/show/NCT01631149 Completed Leiden University Medical Center 2013-03-31
NCT01627522 Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate https://ClinicalTrials.gov/show/NCT01627522 Completed Shiraz University of Medical Sciences 2013-03-31
NCT01604811 Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) https://ClinicalTrials.gov/show/NCT01604811 Completed Pierre Fabre Medicament 2013-10-31
NCT01589263 Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH) https://ClinicalTrials.gov/show/NCT01589263 Completed VA Office of Research and Development 2019-09-30
NCT01577693 Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01577693 Completed GlaxoSmithKline 2011-08-31
NCT01566292 Intraprostatic Botulinum Toxin Type “A” Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy https://ClinicalTrials.gov/show/NCT01566292 Completed Catholic University of the Sacred Heart 2010-09-30
NCT01533038 BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01533038 Completed NeoTract, Inc. 2015-10-31
NCT01500057 Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01500057 Completed Brooklyn Urology Research Group 2016-10-10
NCT01495026 A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia https://ClinicalTrials.gov/show/NCT01495026 Completed GlaxoSmithKline 2012-04-03
NCT01494337 Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) https://ClinicalTrials.gov/show/NCT01494337 Completed Royal Victoria Hospital, Canada 2014-03-31
NCT01471678 Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. https://ClinicalTrials.gov/show/NCT01471678 Completed GlaxoSmithKline 2011-09-07
NCT01460342 Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01460342 Completed Eli Lilly and Company 2012-10-31
NCT01454349 Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01454349 Completed Sophiris Bio Corp 2013-03-31
NCT01438775 Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01438775 Completed Nymox Corporation 2013-01-31
NCT01436877 Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT01436877 Completed Medi-Tate Ltd. 2016-09-30
NCT01387893 A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01387893 Completed Kaiser Permanente 2009-03-31
NCT01342562 The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly https://ClinicalTrials.gov/show/NCT01342562 Completed Yonsei University 2011-10-31
NCT01330927 Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) https://ClinicalTrials.gov/show/NCT01330927 Completed Vantia Ltd 2011-07-31
NCT01330303 SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin https://ClinicalTrials.gov/show/NCT01330303 Completed GlaxoSmithKline 2009-12-22
NCT03595735 The Zenflow Spring System Safety, Performance and Effectiveness Study https://ClinicalTrials.gov/show/NCT03595735 Recruiting Zenflow, Inc. 2020-12-30
NCT04391114 Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04391114 Recruiting Thunder Bay Regional Research Institute 2021-10-15
NCT04386941 Greenlight Vaporization vs Xpeeda Vaporesection https://ClinicalTrials.gov/show/NCT04386941 Recruiting Thunder Bay Regional Research Institute 2022-07-10
NCT04331301 Needlescopic Enucleation Versus Vapoenucleation of BPH https://ClinicalTrials.gov/show/NCT04331301 Recruiting Benha University 2020-08-01
NCT04308070 Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III https://ClinicalTrials.gov/show/NCT04308070 Completed PROCEPT BioRobotics 2018-03-22
NCT04275076 HoLEP Vs BPEP for Large Prostatic Adenoma https://ClinicalTrials.gov/show/NCT04275076 Completed Ain Shams University 2020-02-01
NCT04271020 Urodynamic Feasibility Study Utilizing the UroLift® System https://ClinicalTrials.gov/show/NCT04271020 Completed NeoTract, Inc. 2019-04-22
NCT04263987 A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial https://ClinicalTrials.gov/show/NCT04263987 Recruiting Vanderbilt University Medical Center 2020-05-31
NCT04212403 Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) https://ClinicalTrials.gov/show/NCT04212403 Completed Jessa Hospital 2019-12-23
NCT04198103 Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04198103 Active, not recruiting University of Rome Tor Vergata 2019-11-01
NCT04146103 A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH https://ClinicalTrials.gov/show/NCT04146103 Completed Saint-Joseph University 2019-01-31
NCT04131907 A Clinical Study to Evaluate the Safety and Efficacy of the Optilumeâ„¢ BPH Catheter System in Men With Symptomatic BPH https://ClinicalTrials.gov/show/NCT04131907 Recruiting Urotronic Inc. 2021-06-30
NCT04108871 Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men https://ClinicalTrials.gov/show/NCT04108871 Recruiting The University of Hong Kong 2021-06-01
NCT04107896 Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04107896 Completed Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 2018-08-31
NCT04103450 Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04103450 Enrolling by invitation Urovant Sciences GmbH 2021-07-31
NCT04084938 Artery Embolization vs Operation of Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT04084938 Recruiting Oslo University Hospital 2022-12-31
NCT04044573 Focal Laser Ablation for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04044573 Recruiting University of Rome Tor Vergata 2023-04-05
NCT03972371 The ProVerum First in Man PROVE Study https://ClinicalTrials.gov/show/NCT03972371 Active, not recruiting ProVerum Medical 2021-11-30
NCT03966950 Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia https://ClinicalTrials.gov/show/NCT03966950 Recruiting University of Sao Paulo 2019-11-26
NCT03936244 Bipolar Plasmakinetic TURP Versus Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03936244 Active, not recruiting Hospital Universitario de Fuenlabrada 2017-12-12
NCT03916536 Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate. https://ClinicalTrials.gov/show/NCT03916536 Recruiting Mansoura University 2021-02-01
NCT03912558 Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients. https://ClinicalTrials.gov/show/NCT03912558 Recruiting Butterfly Medical Ltd. 2019-10-31
NCT03902080 Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03902080 Recruiting Urovant Sciences GmbH 2020-11-30
NCT03887871 Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers After Meal https://ClinicalTrials.gov/show/NCT03887871 Completed Chong Kun Dang Pharmaceutical 2019-03-22
NCT03856242 Benign Prostatic Hyperplasia and Ischemic Heart DIsease https://ClinicalTrials.gov/show/NCT03856242 Completed I.M. Sechenov First Moscow State Medical University 2017-09-01
NCT03846700 Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques https://ClinicalTrials.gov/show/NCT03846700 Recruiting University of Bari 2019-10-01
NCT03831321 The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy https://ClinicalTrials.gov/show/NCT03831321 Recruiting Istanbul Medeniyet University 2019-04-22
NCT03829904 The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03829904 Completed Taipei Veterans General Hospital, Taiwan 2020-01-02
NCT03669692 Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. https://ClinicalTrials.gov/show/NCT03669692 Recruiting Complexo Hospitalario Universitario de A Coruña 2022-12-10
NCT03653117 Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT03653117 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2019-07-31
NCT03600766 Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study https://ClinicalTrials.gov/show/NCT03600766 Active, not recruiting Mansoura University 2020-01-01
NCT03577236 The Zenflow Spring System EU Safety and Performance Study https://ClinicalTrials.gov/show/NCT03577236 Recruiting Zenflow, Inc. 2021-12-31
NCT01218243 An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01218243 Completed Guang’anmen Hospital of China Academy of Chinese Medical Sciences 2012-03-31
NCT03554070 Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety https://ClinicalTrials.gov/show/NCT03554070 Active, not recruiting I.M. Sechenov First Moscow State Medical University 2020-03-01
NCT03527589 Embosphere® PROstate Post Market Study https://ClinicalTrials.gov/show/NCT03527589 Active, not recruiting Merit Medical Systems, Inc. 2022-09-01
NCT03503721 Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate https://ClinicalTrials.gov/show/NCT03503721 Recruiting Salzburger Landeskliniken 2021-01-18
NCT03423979 Optilumeâ„¢ BPH Prostatic Drug Coated Balloon Dilation Catheter https://ClinicalTrials.gov/show/NCT03423979 Active, not recruiting Urotronic Inc. 2019-06-04
NCT01260129 Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH https://ClinicalTrials.gov/show/NCT01260129 Completed JW Pharmaceutical 2010-11-30
NCT01259531 Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) https://ClinicalTrials.gov/show/NCT01259531 Completed JW Pharmaceutical 2011-09-30
NCT01254071 A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. https://ClinicalTrials.gov/show/NCT01254071 Completed GlaxoSmithKline 2010-12-21
NCT01222650 A Comparative Study of KSO-0400 in BPH Patients With LUTS https://ClinicalTrials.gov/show/NCT01222650 Completed Kissei Pharmaceutical Co., Ltd. NA
NCT01183650 A Study of Tadalafil in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01183650 Completed Eli Lilly and Company 2011-04-30
NCT01177436 Prostate Cancer Antigen 3 (PCA-3) Gene Project https://ClinicalTrials.gov/show/NCT01177436 Completed Assistance Publique Hopitaux De Marseille 2011-12-31
NCT01152190 A Study in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01152190 Completed Eli Lilly and Company 2012-07-31
NCT01139762 A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms https://ClinicalTrials.gov/show/NCT01139762 Completed Eli Lilly and Company 2012-02-29
NCT01107392 Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01107392 Completed Allergan 2012-03-16
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use https://ClinicalTrials.gov/show/NCT01050465 Completed University of Missouri-Columbia 2010-10-31
NCT01043588 TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management https://ClinicalTrials.gov/show/NCT01043588 Completed Assistance Publique - Hôpitaux de Paris 2009-12-31
NCT01021332 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01021332 Completed Astellas Pharma Inc 2011-12-14
NCT01018511 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01018511 Completed Astellas Pharma Inc 2011-03-31
NCT01002664 Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002664 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002417 MCS in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002417 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT01002274 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002274 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002222 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) https://ClinicalTrials.gov/show/NCT01002222 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT00970632 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00970632 Completed Eli Lilly and Company 2011-01-31
NCT00969072 Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00969072 Completed GlaxoSmithKline 2005-02-28
NCT00962390 Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00962390 Completed Ausio Pharmaceuticals, LLC 2016-01-31
NCT00947882 A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00947882 Completed Ferring Pharmaceuticals 2011-03-31
NCT00945490 Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 https://ClinicalTrials.gov/show/NCT00945490 Completed Nymox Corporation 2014-05-31
NCT00941343 Benign Prostatic Hyperplasia in Taiwan https://ClinicalTrials.gov/show/NCT00941343 Completed Sanofi 2008-09-30
NCT00939120 Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT00939120 Completed Siami, Paul F., M.D. 2014-09-30
NCT00922506 Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00922506 Completed Samsung Medical Center 2014-05-31
NCT00918983 Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00918983 Completed Nymox Corporation 2013-11-30
NCT00918034 Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00918034 Completed Light Sciences Oncology 2011-02-28
NCT00908427 Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00908427 Completed Samsung Medical Center 2006-05-31
NCT00894517 A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00894517 Completed Allergan 2012-06-30
NCT00890851 Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration https://ClinicalTrials.gov/show/NCT00890851 Completed Assistance Publique - Hôpitaux de Paris 2008-12-31
NCT00889707 Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00889707 Completed Sophiris Bio Corp 2009-12-31
NCT00880672 Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate https://ClinicalTrials.gov/show/NCT00880672 Completed Seoul National University Hospital 2008-12-31
NCT00877669 Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH https://ClinicalTrials.gov/show/NCT00877669 Completed Samsung Medical Center 2016-07-31
NCT00861757 Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00861757 Completed Eli Lilly and Company 2010-06-30
NCT00861588 Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00861588 Completed Chinese University of Hong Kong 2007-09-30
NCT00855582 A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00855582 Completed Eli Lilly and Company 2010-07-31
NCT00848081 A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers https://ClinicalTrials.gov/show/NCT00848081 Completed Eli Lilly and Company 2009-12-31
NCT02509975 Safety and Efficacy of OCL 503 in Prostate Artery Embolization https://ClinicalTrials.gov/show/NCT02509975 Completed IMBiotechnologies Ltd. 2018-05-31
NCT00836823 Evaluation of Symptom-specific Goal Achievement https://ClinicalTrials.gov/show/NCT00836823 Completed Samsung Medical Center 2008-08-31
NCT00827814 Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT00827814 Completed Samsung Medical Center 2009-04-30
NCT00827242 Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily https://ClinicalTrials.gov/show/NCT00827242 Completed Eli Lilly and Company 2009-11-30
NCT02737241 HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH https://ClinicalTrials.gov/show/NCT02737241 Completed Mansoura University 2017-03-01
NCT00814736 A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 https://ClinicalTrials.gov/show/NCT00814736 Completed Pfizer 2008-09-30
NCT03887858 Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03887858 Completed Chong Kun Dang Pharmaceutical 2019-03-22
NCT02667938 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules https://ClinicalTrials.gov/show/NCT02667938 Completed Hanmi Pharmaceutical Company Limited 2016-01-31
NCT02578953 Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects https://ClinicalTrials.gov/show/NCT02578953 Completed GlaxoSmithKline 2015-12-15
NCT02431754 A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). https://ClinicalTrials.gov/show/NCT02431754 Completed Eli Lilly and Company 2016-02-29
NCT01829893 PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination https://ClinicalTrials.gov/show/NCT01829893 Completed Korea University Anam Hospital 2012-02-29
NCT03938194 Waterjet Prostate Ablation https://ClinicalTrials.gov/show/NCT03938194 Recruiting Chinese University of Hong Kong 2020-09-30
NCT03758222 Safety and Feasibility of the Mercury Expander System https://ClinicalTrials.gov/show/NCT03758222 Recruiting MedeonBio, Inc. 2020-12-31
NCT00793819 A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00793819 Completed Watson Pharmaceuticals 2009-10-31
NCT00783094 Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension https://ClinicalTrials.gov/show/NCT00783094 Completed Eli Lilly and Company 2009-06-30
NCT00771394 Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00771394 Completed Astellas Pharma Inc 2010-01-31
NCT00759135 Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00759135 Completed Nymox Corporation 2008-01-31
NCT00730418 Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00730418 Completed Samsung Medical Center 2010-03-31
NCT00709488 Phase 1 Study of the Litxâ„¢ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00709488 Completed Light Sciences Oncology 2011-04-30
NCT00706966 MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer https://ClinicalTrials.gov/show/NCT00706966 Completed University of California, San Francisco 2008-12-31
NCT00701779 Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00701779 Completed Siami, Paul F., M.D. 2009-07-31
NCT00700505 A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy https://ClinicalTrials.gov/show/NCT00700505 Completed ThermaRx, Inc. 2009-10-31
NCT00680680 Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker https://ClinicalTrials.gov/show/NCT00680680 Completed Franklin D. Gaylis, MD Inc. 2008-02-29
NCT00670306 Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00670306 Completed AEterna Zentaris 2009-08-31
NCT00663858 Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) https://ClinicalTrials.gov/show/NCT00663858 Completed AEterna Zentaris 2009-09-30
NCT00657839 Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00657839 Completed Bayer NA
NCT00648323 Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement https://ClinicalTrials.gov/show/NCT00648323 Completed Pfizer NA
NCT00645034 A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin https://ClinicalTrials.gov/show/NCT00645034 Completed Pfizer NA
NCT00637715 Once Daily Given Alfuzosin in the Treatment of BPH https://ClinicalTrials.gov/show/NCT00637715 Completed Sanofi NA
NCT00634608 Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow https://ClinicalTrials.gov/show/NCT00634608 Completed University of Missouri-Columbia 2009-03-31
NCT00609596 A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. https://ClinicalTrials.gov/show/NCT00609596 Completed GlaxoSmithKline 2008-04-23
NCT01262989 SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin https://ClinicalTrials.gov/show/NCT01262989 Completed GlaxoSmithKline 2010-01-26
NCT00596011 Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia https://ClinicalTrials.gov/show/NCT00596011 Completed H. Lee Moffitt Cancer Center and Research Institute 2014-03-25
NCT00547625 Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems https://ClinicalTrials.gov/show/NCT00547625 Completed Eli Lilly and Company NA
NCT00540124 Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men https://ClinicalTrials.gov/show/NCT00540124 Completed Eli Lilly and Company 2008-06-30
NCT00537654 A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State https://ClinicalTrials.gov/show/NCT00537654 Completed GlaxoSmithKline 2008-02-22
NCT00527605 Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00527605 Completed GlaxoSmithKline 2009-03-31
NCT00527488 Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. https://ClinicalTrials.gov/show/NCT00527488 Completed Ferring Pharmaceuticals 2009-03-31
NCT00527371 PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate https://ClinicalTrials.gov/show/NCT00527371 Completed St. Joseph’s Healthcare Hamilton 2013-02-28
NCT00517179 Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS https://ClinicalTrials.gov/show/NCT00517179 Completed Hospital Authority, Hong Kong NA
NCT00510406 A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH https://ClinicalTrials.gov/show/NCT00510406 Completed Astellas Pharma Inc 2007-09-30
NCT00475501 5-Alpha Reductase and Anabolic Effects of Testosterone https://ClinicalTrials.gov/show/NCT00475501 Completed VA Office of Research and Development 2012-03-31
NCT00465101 A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization https://ClinicalTrials.gov/show/NCT00465101 Completed American Medical Systems 2012-08-31
NCT00461123 Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy https://ClinicalTrials.gov/show/NCT00461123 Completed Bayer 2008-06-30
NCT00457457 Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. https://ClinicalTrials.gov/show/NCT00457457 Completed Pfizer 2008-04-30
NCT00451191 Botulinum Toxin Injection for the Management of BPH https://ClinicalTrials.gov/show/NCT00451191 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-06-30
NCT00427882 Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study https://ClinicalTrials.gov/show/NCT00427882 Completed Handok Inc. NA
NCT00427219 The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate https://ClinicalTrials.gov/show/NCT00427219 Completed Spectrum Pharmaceuticals, Inc 2008-04-30
NCT00416390 Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00416390 Completed National Cancer Institute (NCI) NA
NCT00409357 Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00409357 Completed Sanofi 2005-08-31
NCT00408954 Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT00408954 Completed Pfizer 2008-06-30
NCT00401661 Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin https://ClinicalTrials.gov/show/NCT00401661 Completed Sanofi 2007-12-31
NCT00399464 Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00399464 Completed Sanofi 2007-10-31
NCT00386009 Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00386009 Completed Eli Lilly and Company 2008-05-31
NCT00384930 Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00384930 Completed Eli Lilly and Company 2007-10-31
NCT00382356 Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) https://ClinicalTrials.gov/show/NCT00382356 Completed North Florida/South Georgia Veterans Health System 2009-07-31
NCT00379067 A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. https://ClinicalTrials.gov/show/NCT00379067 Completed Astellas Pharma Inc 2006-11-30
NCT00375765 Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer https://ClinicalTrials.gov/show/NCT00375765 Completed GlaxoSmithKline 2007-07-31
NCT00368979 Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects https://ClinicalTrials.gov/show/NCT00368979 Completed GlaxoSmithKline 2007-12-01
NCT00364585 A Prospective Evaluation of the GreenLight Model 120 Laser https://ClinicalTrials.gov/show/NCT00364585 Completed Weill Medical College of Cornell University NA
NCT00359905 Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH https://ClinicalTrials.gov/show/NCT00359905 Completed Recordati Industria Chimica e Farmaceutica S.p.A. 2007-05-31
NCT00347061 Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH https://ClinicalTrials.gov/show/NCT00347061 Completed Sanofi 2007-10-31
NCT00290030 ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH https://ClinicalTrials.gov/show/NCT00290030 Completed Sanofi 2004-10-31
NCT00284518 Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00284518 Completed Allergan 2009-05-31
NCT00280605 ALF-ONE : ALFuzosin ONcE Daily https://ClinicalTrials.gov/show/NCT00280605 Completed Sanofi 2006-02-28
NCT00224133 The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months https://ClinicalTrials.gov/show/NCT00224133 Completed Watson Pharmaceuticals 2007-04-30
NCT00224120 A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo https://ClinicalTrials.gov/show/NCT00224120 Completed Watson Pharmaceuticals 2006-05-31
NCT00224107 A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo https://ClinicalTrials.gov/show/NCT00224107 Completed Watson Pharmaceuticals 2006-08-31
NCT00199550 Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) https://ClinicalTrials.gov/show/NCT00199550 Completed Lawson Health Research Institute 2008-03-31
NCT00194675 TRADE-Testosterone Replacement and Dutasteride Effectiveness https://ClinicalTrials.gov/show/NCT00194675 Completed University of Washington 2010-04-30
NCT00169585 Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) https://ClinicalTrials.gov/show/NCT00169585 Completed GlaxoSmithKline 2007-04-30
NCT00143221 Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00143221 Completed Pfizer NA
NCT00127179 A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) https://ClinicalTrials.gov/show/NCT00127179 Completed Merck Sharp & Dohme Corp. 2005-07-01
NCT00111592 Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice https://ClinicalTrials.gov/show/NCT00111592 Completed Maastricht University Medical Center NA
NCT00090103 Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment https://ClinicalTrials.gov/show/NCT00090103 Completed GlaxoSmithKline 2009-04-30
NCT00077012 Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00077012 Completed QLT Inc. 2005-05-31
NCT00062790 Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels https://ClinicalTrials.gov/show/NCT00062790 Completed GlaxoSmithKline NA
NCT00797394 Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto https://ClinicalTrials.gov/show/NCT00797394 Completed innoVactiv Inc. 2010-07-31
NCT00037154 Saw Palmetto Extract in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00037154 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00037141 Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00037141 Completed American Medical Systems NA
NCT00029822 Clinical Trial in Males With BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT00029822 Completed Sanofi NA
NCT00486785 SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin https://ClinicalTrials.gov/show/NCT00486785 Completed Sanofi 2007-10-31
NCT00021814 Medical Therapy of Prostatic Symptoms https://ClinicalTrials.gov/show/NCT00021814 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2001-11-30
NCT00540891 The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score https://ClinicalTrials.gov/show/NCT00540891 Completed Sanofi NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03228485 Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study https://ClinicalTrials.gov/show/NCT03228485 Recruiting Société Internationale d’Urologie 2021-04-10
NCT03179670 Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH https://ClinicalTrials.gov/show/NCT03179670 Completed Laboratoires Bouchara-Recordati 2018-06-30
NCT02873117 Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers https://ClinicalTrials.gov/show/NCT02873117 Completed Rennes University Hospital 2016-12-31
NCT02483819 Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients https://ClinicalTrials.gov/show/NCT02483819 Completed Yonsei University 2016-02-27
NCT02425800 Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells https://ClinicalTrials.gov/show/NCT02425800 Completed Wake Forest University Health Sciences 2018-11-05
NCT02347436 Does Benign Prostatic Obstruction Cause Hypertension? https://ClinicalTrials.gov/show/NCT02347436 Completed St. Olavs Hospital 2019-10-31
NCT02248467 Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients https://ClinicalTrials.gov/show/NCT02248467 Completed University of Florence 2017-12-31
NCT02245555 Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02245555 Completed Boehringer Ingelheim 2007-12-31
NCT02245542 The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) https://ClinicalTrials.gov/show/NCT02245542 Completed Boehringer Ingelheim 2006-02-28
NCT02245529 Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02245529 Completed Boehringer Ingelheim 2005-09-30
NCT02245503 Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02245503 Completed Boehringer Ingelheim 2003-10-31
NCT02244346 Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02244346 Completed Boehringer Ingelheim 2004-11-30
NCT02244333 Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS) https://ClinicalTrials.gov/show/NCT02244333 Completed Boehringer Ingelheim 2004-07-31
NCT02244320 Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin) https://ClinicalTrials.gov/show/NCT02244320 Completed Boehringer Ingelheim 2003-05-31
NCT02244307 Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade https://ClinicalTrials.gov/show/NCT02244307 Completed Boehringer Ingelheim 2003-06-30
NCT02244268 Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02244268 Completed Boehringer Ingelheim 2001-12-31
NCT02206243 Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02206243 Completed Jena University Hospital 2018-11-30
NCT01299571 AVODART(Dutasteride) Post-marketing Surveillance(PMS) https://ClinicalTrials.gov/show/NCT01299571 Completed GlaxoSmithKline 2010-07-31
NCT03354416 Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer https://ClinicalTrials.gov/show/NCT03354416 Recruiting National Institutes of Health Clinical Center (CC) 2027-12-31
NCT01958892 To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate https://ClinicalTrials.gov/show/NCT01958892 Completed Singapore General Hospital 2012-10-31
NCT01767363 WEUSKOP5723: Prostate Cancer Study https://ClinicalTrials.gov/show/NCT01767363 Completed GlaxoSmithKline 2016-03-31
NCT01604148 Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon https://ClinicalTrials.gov/show/NCT01604148 Completed Samsung Medical Center 2011-07-31
NCT01534793 QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) https://ClinicalTrials.gov/show/NCT01534793 Completed Assistance Publique - Hôpitaux de Paris 2013-05-31
NCT01482676 The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction https://ClinicalTrials.gov/show/NCT01482676 Completed University Hospital Inselspital, Berne 2012-12-31
NCT01435954 Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy https://ClinicalTrials.gov/show/NCT01435954 Completed GlaxoSmithKline 2011-03-31
NCT01390870 Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence https://ClinicalTrials.gov/show/NCT01390870 Completed GlaxoSmithKline 2010-09-30
NCT01386983 Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment https://ClinicalTrials.gov/show/NCT01386983 Completed GlaxoSmithKline 2010-06-30
NCT01381510 Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database https://ClinicalTrials.gov/show/NCT01381510 Completed GlaxoSmithKline 2010-08-31
NCT01376284 Drug Use Investigation for AVOLVE(BPH) https://ClinicalTrials.gov/show/NCT01376284 Completed GlaxoSmithKline 2013-10-31
NCT01376258 Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database https://ClinicalTrials.gov/show/NCT01376258 Completed GlaxoSmithKline 2010-12-31
NCT01371513 Korean Practice Patterns for Screening PCA(Prostate Cancer) https://ClinicalTrials.gov/show/NCT01371513 Completed GlaxoSmithKline 2011-06-30
NCT01337258 Economic Analyses of the REDUCE Trial https://ClinicalTrials.gov/show/NCT01337258 Completed GlaxoSmithKline 2010-07-31
NCT01334723 Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01334723 Completed GlaxoSmithKline 2010-04-30
NCT01332487 Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01332487 Completed GlaxoSmithKline 2010-08-31
NCT01332435 Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use https://ClinicalTrials.gov/show/NCT01332435 Completed GlaxoSmithKline 2010-01-31
NCT01323998 Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan https://ClinicalTrials.gov/show/NCT01323998 Completed GlaxoSmithKline 2010-06-30
NCT04383093 Tadalafil Plus Tamsulosin for Male LUTS and ED https://ClinicalTrials.gov/show/NCT04383093 Completed University of Florence 2018-01-01
NCT03991429 Brain Imaging in Men With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT03991429 Enrolling by invitation The Methodist Hospital System 2021-04-01
NCT03959917 TURP; Complications and Outpatient Care https://ClinicalTrials.gov/show/NCT03959917 Recruiting Umeå University 2020-02-15
NCT03955484 Benign Prostatic Hyperplasia and Glycosaminoglycan https://ClinicalTrials.gov/show/NCT03955484 Recruiting Marmara University 2019-09-01
NCT03912766 Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy https://ClinicalTrials.gov/show/NCT03912766 Completed Medical Universtity of Lodz 2017-01-02
NCT03768765 Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03768765 Recruiting University of Kansas Medical Center 2020-12-31
NCT03630926 Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. https://ClinicalTrials.gov/show/NCT03630926 Active, not recruiting Intermountain Health Care, Inc. 2019-08-31
NCT03460873 Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate https://ClinicalTrials.gov/show/NCT03460873 Completed Samsung Medical Center 2019-11-07
NCT01250483 Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT01250483 Completed Seoul National University Hospital 2009-12-31
NCT01108367 Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) https://ClinicalTrials.gov/show/NCT01108367 Completed Seoul National University Hospital 2010-03-31
NCT01003886 A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01003886 Completed Pfizer 2011-01-31
NCT00885027 MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment https://ClinicalTrials.gov/show/NCT00885027 Completed Boehringer Ingelheim 2009-04-30
NCT03486639 Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity https://ClinicalTrials.gov/show/NCT03486639 Recruiting Assaf-Harofeh Medical Center 2020-04-01
NCT00822952 Prostate Mechanical Imager (PMI) Clinical Bridging Study https://ClinicalTrials.gov/show/NCT00822952 Completed Artann Laboratories 2009-09-30
NCT03075449 Real World Data on Management of Male LUTS https://ClinicalTrials.gov/show/NCT03075449 Completed Boehringer Ingelheim 2016-12-21
NCT02940977 Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique https://ClinicalTrials.gov/show/NCT02940977 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2019-03-30
NCT02304549 A Prospective Investigation Using the Expired Breath Ethanol Test https://ClinicalTrials.gov/show/NCT02304549 Completed Cantonal Hospital of St. Gallen 2015-11-30
NCT00662350 Temperature Mapping of the Prostate With the Walltermâ„¢ System https://ClinicalTrials.gov/show/NCT00662350 Completed Pnn Medical A/S 2009-07-31
NCT00593593 Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia https://ClinicalTrials.gov/show/NCT00593593 Completed GlaxoSmithKline NA
NCT00472251 One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients https://ClinicalTrials.gov/show/NCT00472251 Completed Seoul National University Hospital 2008-09-30
NCT00427817 PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma https://ClinicalTrials.gov/show/NCT00427817 Completed University Hospital, Grenoble 2009-01-31
NCT00407329 Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00407329 Completed Queen’s University 2008-02-29
NCT00316732 Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS https://ClinicalTrials.gov/show/NCT00316732 Completed GlaxoSmithKline 2006-12-19
NCT00187616 Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT00187616 Completed University of California, San Francisco NA
NCT00159406 Laser Prostatectomy Database and Registry https://ClinicalTrials.gov/show/NCT00159406 Active, not recruiting Indiana Kidney Stone Institute 2020-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02029560 Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System https://ClinicalTrials.gov/show/NCT02029560 Completed JW Pharmaceutical 2014-11-30
NCT01886547 2013 Annual National Digital Rectal Exam (DRE) Day Study https://ClinicalTrials.gov/show/NCT01886547 Completed St. Luke’s Medical Center, Philippines 2014-10-31
NCT01826617 Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome https://ClinicalTrials.gov/show/NCT01826617 Completed St. Luke’s Medical Center, Philippines 2014-11-30
NCT04352257 Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04352257 Recruiting Kafrelsheikh University 2021-04-01
NCT03736512 China Greenlight Registry Study (Post-market) https://ClinicalTrials.gov/show/NCT03736512 Recruiting Boston Scientific Corporation 2020-06-30
NCT03583034 Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands https://ClinicalTrials.gov/show/NCT03583034 Recruiting IRCCS San Raffaele 2019-04-18
NCT03521648 Database for the Assessment of Efficacy and Safety of BPH Treatment https://ClinicalTrials.gov/show/NCT03521648 Recruiting Cantonal Hospital of St. Gallen 2027-12-01